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Abstract
Given the sensitivity of proton therapy to anatomical variations, this cancer treatment modality is expected
to benefit greatly from integration with magnetic resonance (MR) imaging. One of the obstacles hindering
such an integration are strong magnetic field induced dose distortions. These have been predicted in simula-
tion studies, but no experimental validation has been performed so far. Here we show the first measurement
of planar distributions of dose deposited by therapeutic proton pencil beams traversing a one-Tesla transver-
sal magnetic field while depositing energy in a tissue-like phantom using film dosimetry. The lateral beam
deflection ranges from one millimeter to one centimeter for 80 to 180 MeV beams. Simulated and measured
deflection agree within one millimeter for all studied energies. These results proof that the magnetic field
induced proton beam deflection is both measurable and accurately predictable. This demonstrates the feasi-
bility of accurate dose measurement and hence validates dose predictions for the framework of MR-integrated
proton therapy.
With about half of all cancer patients undergoing radiation therapy, this modality has become one of
the three pillars of modern cancer treatment next to chemotherapy and surgery [1]. Radiation therapy
makes use of ionising radiation, usually high-energetic photons, in order to irreversibly damage the DNA
and chromatin of clonogenic tumour cells, and thereby prevent these cells from proliferating. Over the last
two decades, the use of accelerated protons has emerged as an important treatment option, especially for
tumours of the central nervous system and for paediatric cases [2, 3]. As compared to conventional photon-
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based radiation therapy, proton therapy utilizes the electromagnetic properties of charged particles giving
rise to a depth-dose distribution that is characterized by a steep dose maximum at the so-called Bragg peak,
with almost no dose beyond the peak. The Bragg peak can be positioned to cover the tumour volume in
depth by adjustment of its energy, and laterally by use of dipole magnets or collimation devices. This allows
to deliver dose distributions with improved conformality to the tumour volume and hence a better sparing
of healthy tissue, especially beyond the tumour.
At the same time, the steepness of the Bragg peak and its positional dependence on the material compo-
sition in the beam path make proton treatment far more sensitive to morphological changes in the patient
than photon (or X-ray) therapy. Possible anatomical alterations and differences in patient positioning be-
tween irradiations (interfractional uncertainties), as well as organ motion and deformation during irradiation
(intrafractional uncertainties, e.g. due to respiration, muscle tension and digestion) lead to considerable un-
certainties in the dose delivery. These uncertainties currently translate into large treatment margins around
the tumour und thus compromise the dosimetric benefit of proton therapy, which may lead to undesired side
effects for the patients (treatment toxicity).
One strategy to reduce such side effects is to monitor the patient’s anatomy during dose delivery in real-
time and to adapt the beam accordingly. Providing unmatched soft-tissue contrast, subsecond temporal
resolution and freedom from ionizing radiation dose, Magnetic Resonance Imaging (MRI) appears to be an
ideal candidate for anatomy monitoring during treatment delivery [4, 5]. For photon beam therapy, the
integration of both modalities has already been realized, and first-generation hybrid systems have recently
found their way into clinical application [6, 7, 8, 9].
Because of the high anatomical sensitivity of proton therapy mentioned above, the integration of MRI
into proton therapy (MRiPT) is expected to be even more beneficial than for photon therapy and thus has
gained interest in the last years [10]. However, MRiPT has only been studied on a conceptual level thus
far, as a number of technical and physical challenges need to be overcome. Complex mutual interactions
are expected between the transient electromagnetic fields of the MR scanner and the proton beam line
[11]. Furthermore, unlike photons, protons being charged particles are subject to the Lorentz force when
traversing the magnetic field of an MRI scanner, causing the beam to be deflected from its otherwise straight
path. This is a well-understood and benchmarked phenomenon in vacuum. However, for protons interacting
with substances of the human body (e.g. tissue, bone, air, fat, blood), a continuous energy loss will affect
the local curvature of the beam as it penetrates the body. So far, only simulation studies exist investigating
this effect using particle tracking algorithms in a water phantom or patient geometry. Severe distortions
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Figure 1: Schematic sagittal view (a) and photograph (b) of the experimental setup. The proton beam passed through
collimators (C) and a slab phantom (P) placed inside the field of a permanent magnet (M). The dose in the phantom was
measured using a Gafchromic film detector. A left-handed coordinate system is used. Photo edited for clarity.
of the dose distribution in the patient have been predicted; particularly, the Bragg peak is expected to
be displaced by a few millimeters up to several centimeters, depending on beam energy and magnetic flux
density [12, 13, 14, 15, 16, 17, 18].
For the design of dose distributions during treatment planning, the dose simulation models predicting
these effects need to be validated with measurements. Hence experimental benchmark data is required.
However, such data does not exist, thereby inhibiting the employment of the models used in simulation
studies for potential clinical use.
For this purpose, measurements are needed involving a clinical proton pencil beam (beam energy E0
between 70 MeV and 230 MeV), a magnet whose flux density is in the clinical range (B0 = 0.35...3 T), a
tissue-like phantom (density ρ ≈ 1 gcm−3), and a dosimeter having an adequate spatial resolution (∆x <
1 mm) as well as a magnetic field-independent dose response.
Here we describe the first measurement of magnetic field induced dose distortion of a slowing-down
therapeutic proton pencil beam within a tissue-like medium, and a comparison to state-of-the-art dose
simulations based on Monte Carlo particle tracking.
Proton dose measurement within a magnetic field
The measurement setup is depicted in Figure 1. It consists of a collimated proton beam, a slab phantom
containing a horizontally placed film dosimeter, and a permanent magnet assembly.
The proton beam was generated by an isochronous cyclotron (C230, IBA, Louvain-La-Neuve, Belgium)
at the proton therapy facility of our institution. The horizontal static beam line was used and defined the
3
x-axis of the setup. Beams of energy E0 between 80 MeV and 180 MeV were used and collimated to pencil
beams of 1 cm diameter in order to prevent the magnet from being damaged from direct radiation exposure.
A slab phantom was produced from polymethyl methacrylate (PMMA, ρ = 1.186 gcm−3) and mounted
horizontally in the air gap between the poles of a C-shaped permanent magnet assembly. It consisted of
two slabs, such that a film dosimeter was placed horizontally in the central plane parallel to the beam. The
contact area of the slabs was bevelled by α = 1◦ to reduce the dependence of the dose distribution on the
film material and a possible air gap between the phantom and film [19]. Two vertically oriented pins in the
phantom and corresponding holes in the films ensured a reproducible alignment of the film relative to the
phantom.
A self-developing Gafchromic EBT3 film detector of 280 µm thickness (Ashland, Covington, USA) was
used to measure the planar dose distributions in the central plane of the proton beam, as it provides a
submillimeter spatial resolution and is largely unaffected by magnetic fields [20].
The phantom and film detector were placed inside a transversal magnetic field (see Supporting Figure
A.7) produced by a magnet assembly consisting of two Nd2Fe14B permanent magnet poles and a yoke.
The maximum magnetic flux density of B0 = 0.95 T was chosen to be comparable to that of existing MR-
integrated photon therapy systems with flux densities between 0.35 T and 1.5 T [6, 7, 8, 9]. The main field
component was aligned parallel to the z-axis (pointing downwards), and caused a deflection of the proton
beam in the (positive) y-direction.
Prior to the first irradiation experiment, all three magnetic field components were mapped at 5 mm reso-
lution using an automated magnetometry setup, comprising of a robotic positioning device and a Hall probe
(MMTB-6J04-VG, Lake Shore Cryotronics, Westerville, USA) that was connected to a digital Gaussmeter
(Model 421, Lake Shore Cryotronics) [21]. To monitor the main field component’s temporal stability, point
measurements along the central x-axis at 5, 10 and 15 cm depth relative to the phantom’s front face were
performed after each irradiation experiment. Deviations were within 3 mT, which was smaller than the
measurement precision (4 mT), and not systematic.
Further details of the experimental setup can be found in Supporting Appendix A.1.
Beam deflection and Bragg peak dislocation
The influence of the magnetic field on the proton dose distribution could be observed on the film dosimeter
signal, as depicted for 180 MeV in Figure 2. The characteristic shape of the proton dose distribution was
visible both with and without magnetic field, but with magnetic field the beam followed a deflected trajectory
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Figure 2: Relative dose distribution of a 180 MeV proton beam in PMMA on the film dosimeter, without (redscale) and with
(bluescale) magnetic field. (a): Top view, (b): side view.
Figure 3: Relative measured depth-dose curves with (solid lines) and without (dashed) magnetic field.
resulting in a laterally shifted Bragg peak position.
To investigate the impact of the magnetic field on the range of the beam (i.e. Bragg peak retraction),
depth-dose curves were reconstructed from the film dose distributions by a radial integration method (see
Supporting Appendix C and Figure 3). From these, the proton range R80, defined as the penetration
depth of the beam at the 80 % distal end of the Bragg peak maximum, was extracted both with and without
magnetic field. Bragg peak retraction was found to be below 0.5 mm for all studied energies. Small deviations
were found between depth-dose curves with and without magnetic field in the plateau region (see Figure 3),
however, repeated experiments showed that these were due to statistical setup uncertainties (see Supporting
Appendix B.4) rather than the magnetic field. No magnetic-field induced change in the absolute measured
dose was observed, showing the suitability of Gafchromic EBT3 film dosimeters for this experiment.
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To quantify the lateral Bragg peak dislocation, the central trajectory of the deflected beam was recon-
structed using a depth layer-wise Gaussian fitting method (see Supporting Appendix C and Figure 4). The
extracted Bragg peak dislocation ranged from 1 mm for 80 MeV up to 10 mm for 180 MeV.
Note that the deflected beam trajectories did not coincide for different energies, but fanned out energy-
dependently, as the radius of beam path increases with increasing proton energy [13, 18]. For high energies
(most prominently 180 MeV), trajectories appeared inflected in the opposite direction towards the end of the
beam path. This can be explained by a combination of two effects. Firstly, the radial integration planes are
increasingly less perpendicular to the beam direction. Secondly, within the energy spectrum of the beam,
protons with higher energies are less deflected by the Lorentz force than those with smaller energies. Thus,
at high depths, only long range (high initial energy) protons remain, which shift the central beam trajectory
towards smaller deflection (energy separation effect [17]).
Measured deflection and retraction values and their uncertainties are detailed in Supporting Table D.5.
Agreement with computational model
The measured data allowed for a verification of the dose prediction in magnetic fields by Monte Carlo
based particle tracking simulations, being considered as the gold standard for dose prediction in radiation
therapy planning. For this study, such simulations were performed using the Geant4 toolkit version 10.2.p02
[22, 23]. Details on the simulation beam model can be found in Supporting Appendix B.1.
The shape of the predicted dose distributions agreed with the measured distributions, as shown exem-
plarily for a 160 MeV proton beam in Figure 5. Due to saturation of the film signal caused by the particles’
increasing energy deposition per path length, differences between predicted and measured dose increased
Figure 4: Predicted (solid lines) and measured (dashed) deflected central beam trajectories for different beam energies. Error
bars refer to systematic and statistical uncertainties given in Supplement Tables A.1 and B.4.
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Figure 5: Top panel: Predicted (green) and measured (copper) dose distribution of a 160 MeV proton beam in PMMA
without (a) and with magnetic field (b). Dose is given in percent relative to the median dose in the central plateau region
(1.9 cm ≤ x ≤ 2.1 cm and −0.5 cm ≤ y ≤ 0.5 cm).
Figure 6: Predicted and measured Bragg peak displacement in lateral (solid) and longitudinal (dashed) direction for discrete
beam energy levels. Error bars refer to systematic and statistical uncertainties given in Supplement Tables A.1 and B.4.
Individual data points are interconnected for visualization only.
towards the Bragg peak. The difference in the absolute Bragg peak dose was consistent with the findings
of previous studies [19, 24, 25], and was not increased by the magnetic field. Thus, the introduction of a
magnetic field did not compromise the dose prediction accuracy.
To quantify the accuracy of the calculated Bragg peak position, its retraction and deflection were com-
pared (see Figure 6). Both quantities agreed within measurement and simulation uncertainties (0.8 mm) for
all studied energies. There was no systematic difference in Bragg peak retraction and deflection between
the simulation and measurement data.
Conclusions
For the first time, magnetic field induced dose distortions of a slowing-down therapeutic proton beam in a
tissue-like medium have been measured and compared against particle tracking simulations. In a transverse
magnetic field of 0.95 T, it was shown that lateral Bragg peak displacement ranges between 1 mm and 10 mm
for proton energies between 80 and 180 MeV in PMMA. Range retraction was found to be ≤ 0.5 mm, which
7
is clinically acceptable. These results were shown to agree within 0.8 mm with Monte Carlo based particle
tracking simulations.
The obtained range of 1 mm to 10 mm Bragg peak displacement corresponds very well with previous
theoretical studies in a homogeneous magnetic field in water [17, 18]. For inhomogeneous media, a magnetic
field induced dose increase at medium-air material boundaries in the order of 2 % has been predicted caused
by electrons returning to the material boundary after being deflected by Lorentz force in air (electron return
effect [17]). The experimental verification thereof is subject of an ongoing study.
This study showed for the first time that the magnetic field induced proton dose distortion is both
measurable and accurately predictable in a tissue-like beam stopping medium. This validates the models
used by Monte Carlo simulations and allows them to be used for accurate dose prediction in future treatment
planning studies on MR-integrated proton therapy.
Methods
Details on the experimental setup and the Monte Carlo model as well as an estimation of sources of
uncertainty can be found in the Supplementary Information section.
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Supplementary Information
Details on the material and methods used for this study are given in the following sections.
Appendix A. Experimental measurements
Appendix A.1. Experimental setup
The experimental setup is displayed in Figure 1. Details are given in this section.
The beam defines the x-axis of the setup. Energies between 80 and 180 MeV were used to place the
Bragg peak inside the main magnetic field (as would be the case in a clinical situation of MR-integrated
proton therapy).
In order to reduce the particle fluence on the magnets and the yoke and thus to prevent radiation
damage, the beam was collimated by two brass collimators with a circular aperture of 10 mm diameter.
The collimators had a cylindrical shape with an outer radius of 9 cm and a combined thickness of 6.6 cm.
This thickness allows to fully stop peripheral protons for all used energies up to 180 MeV. The distance
between the beam exit window and the surface of the first collimator was 1.63 m, and that between the two
collimators was 2 cm. The large distance between the beam exit and the collimators was chosen to improve
the lateral beam homogeneity by increased scattering in air. The collimators were placed in the beam line
such that a symmetric beam profile was achieved behind the collimators (see Extended Data, Figure A.8).
The collimated beam travelled 22 cm through air before it impinged on the phantom, which was placed
centrally in the beam’s isocentre inside a transverse magnetic field. The phantom comprised two slabs of
polymethyl methacrylate (PMMA) and measured xph × yph × zph = 30× 15× 3 cm3. The density of the
PMMA was (1.186± 0.002)g cm−3 as measured by density determination scales. The phantom was mounted
into the air gap of the magnet assembly by an L-shaped holder.
In order to measure planar dose distributions in the isocentre plane, a film detector was placed horizon-
tally in the phantom. The film was bevelled by α = 1◦ to reduce the dependence of the dose distribution
on the film material and possible air gaps between phantom and film. An angle of α = 1◦ was chosen as
it tilted the measurement plane minimally out of the central beam plane whilst suppressing these effects as
good as larger angles [19]. With this angle, the inclination lead to differences in x below 0.02 mm. However,
we note that this tilt makes the resulting depth-dose curves not directly comparable to those which would
be obtained with an ionization chamber moving along the central beam axis due to the laterally sloping
beam profile. The air gap between the phantom and the film was minimized by four plastic screws pressing
the slabs together.
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The magnet assembly consists of two magnet poles with a size of xpole × ypole × zpole = 20× 15× 5.9 cm3
each and a density of 7.6 g cm−3 [26]. The two poles made up of Nd2Fe14B are mounted on a C-shaped yoke,
mounted on a mobile table. The air gap between the poles has a height of 4 cm.
As opposed to a previous study for photons [27], no systematic differences in absolute dose were found
between the film measurements with and without magnetic field, which may be caused by the fact that film
dosimeters were oriented perpendicular to the magnetic field in this study.
Appendix A.2. Film handling and evaluation
EBT3 Gafchromic films (Ashland, Covington, USA; lot 05201501) cut to (20× 15) cm2 were used to
measure the planar dose distribution of the beam. They were scanned with a flat-bed document scanner
(Expression 11000XL, Epson America, Long Beach, CA) in landscape orientation, transmission mode, 24-bit
color mode, and a resolution of 300 dpi.
Scanned images were analysed using in-house developed software written in the Python programming
language (Python Software Foundation). The net optical density (netOD) was computed from the red
channel pixel intensity I and background intensity I0 for each pixel i as
netODi = log10
I0
Ii
, (A.1)
and converted to dose using the calibration
Di = k1(netODi) + k2(netODi)
k3 (A.2)
with k1 = 8.36, k2 = 10.71 and k3 = 1.84. The calibration had been performed in analogy to a previous
study [28]. The first 30 pixels (2.55 mm) around film cutting edges were omitted.
Pixels were converted to x-y-coordinates as follows. Pixels were scaled with the image resolution, yielding
a distribution on the film plane in x′ and y′. This coordinate system is tilted by α = 1◦ around the y-axis
relative to the system defined above, which yields x = cos(α)x′ and y = y′. Note that x − x′ < 0.02 mm
within the film. The pinholes on the scanned images, whose x-y-positions are given by the manufacturer,
were automatically detected on the scanned images and hence defined a translation and rotation of the dose
distribution.
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Appendix A.3. Out-of-plane beam deflection
A transmission irradiation experiment was performed to ensure that the beam was not deflected out of
the film (x-y-) plane by magnetic field components pointing along the y-axis. For this purpose, the phantom
was removed and a pixelated scintillation detector with a resolution of 0.5 mm (Lynx, IBA Dosimetry,
Schwarzenbruck, Germany) was placed behind the magnet assembly in a distance of 24 cm. As depicted in
Extended Data Figure A.9a, the out-of-plane deflection due to the magnetic field was within measurement
uncertainty.
The deflection in y-direction observed on the scintillation detector yLynx is depicted in Extended Data
Figure A.9b. We note that, assuming a uniform magnetic flux density B = 0.95 T between the magnet poles
and no magnetic field outside, yLynx can be easily approximated by trigonometric considerations from the
length of the magnet poles xpole and the distance between the magnet and the scintillation device dair as
yLynx = r −
√
r2 − x2pole +
dair√
r2 − dair
. (A.3)
Neglecting relativistic effects and beam energy loss in air, the radius of the beam path inside the magnetic
field is r ≈ 14.4
√
E0
B0
T cm (MeV)−
1
2 , and a function of the initial proton energy E0 [16]. Values for yLynx
obtained with this approximation for a nominal distance between magnet and detector screen of dair = 26 cm
show excellent agreement with the measured positions (see Extended Data, Figure A.9b). The difference of
dair to the measured distance between the magnet and the detector can be ascribed to the distance between
the active scintillation layer and the detector’s surface and the non-uniformity of the magnetic field.
Appendix A.4. Uncertainty estimation
The influence of the measurement uncertainties on the Bragg peak lateral deflection ∆y80 and range
retraction ∆R80 was assessed as follows (see Table A.1).
Statistical uncertainties such as the robustness of the ∆R80- and ∆y80-determination, and possible
remaining displacement of the film relative to the phantom and to the scanner have been assessed by
repeating the measurement for 180 MeV three times. Mean absolute deviations were used as statistical
uncertainties.
Film-to-film variations and the film calibration are subject to percentual dose uncertainties. The cali-
bration has a relative dose uncertainty of 5 % [28]. Dose uncertainties due to film and scanner variations
add up to 0.5 % [29]. Being proportional to the dose, these uncertainties were considered to have negligible
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influence on ∆R80 and ∆y80, which only depend on the relative dose difference between the measurement
with and without magnetic field.
The influence of the LET dependence of the film response was assessed by applying a polynomial cor-
rection function [19] to the depth-dose curves. Taking into account the film-, energy-, dose- and possible
setup-dependence of this method, this correction is not directly transferrable to this study but serves as a
measure to estimate the influence of this effect. Thus, we estimate the uncertainty caused by this effect to
be as high as the difference in ∆R80 and ∆y80 between the corrected and uncorrected data.
The setup was aligned using the in-room laser system, rulers and a spirit level. Systematic setup uncer-
tainties are related to translational and rotational degrees of freedom.
A rotation of the film dosimeter relative to the beam axis has a direct impact on the mesured peak
deflection. The alignment of the axes of the beam and the laser positioning system was uncertain to
within 0.1 o. The consequence of this angle on Bragg peak retraction and deflection have been assessed by
purposefully rotating the dose distribution by this angle.
Rotation of the magnet relative to the laser and of the phantom relative to the magnet were assessed by
repeating the setup and irradiation procedure. For this analysis, the beam trajectory was determined for
each depth as the mean of the two lateral positions receiving 10 % of the maximum dose. As no systematic
dependence on the beam energy was observed in the deviations between the two experiments, mean absolute
deviations were used as an estimate for this uncertainty. Rotations of the film relative to the phantom are
statistical and therefore already covered.
Translational uncertainties in x-direction were considered to be negligible, as they mostly lead to un-
certainties in the amount of air traversed. An exception to this is the uncertainty of the pin positions (see
Supporting Appendix A.1), which was below 10µm and therefore negligible. Translational uncertainties in
y-direction were suppressed by setting the mean of the y-coordinate of the trajectory in the first 10 pixels
to zero. Proton beam deflection in the magnetic fringe field outside of the magnet assembly was considered
negligible.
Another factor of uncertainty was introduced by the initial spatial achromaticity of the beam, i.e. a
y-z-dependent energy spectrum, caused by the beam line design. This resulted in a kink towards the end of
the trajectory, which lead to an overestimation of the beam deflection. This effect was observed both with
and without magnetic field. The kink is about 3 mm in x- and 0.2 mm in y-direction.
Relevant sources of uncertainty are summarized and quantified in Supporting Table A.1. The total
uncertainty was estimated as the square root of the quadratic sum of the individual contributions.
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(a) (b)
Figure A.7: Central plane of the measured magnetic field (a) and central field profiles (b) along the x-(blue) and y-(orange)
axes. Values for y > 7.5 cm are not displayed due to the presence of the magnet yoke.
(a) (b)
Figure A.8: Measured beam profiles at the distal edge of the collimators. (a) Exemplary 2D beam profile for 180 MeV and
(b) central line profiles for different energies between 80 and 180 MeV. Profiles were measured with an EBT3 film dosimeter
attached to the back of the last collimator, perpendicular to the beam.
(a) (b)
Figure A.9: Measured beam deflection in z- (a) and y-direction (b) on the scintillation detector after transmission through
the magnet air gap without phantom. Positions of beam profile maxima with (orange) and without (blue) the magnet in place
are displayed.
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Table A.1: Uncertainties of the measured lateral deflection ∆y80 and range retraction ∆R80 of the Bragg peak. Lower and
upper limits are given for energy-dependent effects, where lower energies are related to smaller uncertainties.
Source of uncertainty ∆R80/mm ∆y80/mm
Statistical 0.4 0.2
Sytematic 0.3 ... 0.4 0.4
Thereof:
LET dependence 0.0 ... 0.2 0.0 ... 0.2
Setup axis alignment 0.3 0.3
Beam achromaticity < 0.01 0.2
Total 0.5 0.4 ... 0.5
Appendix B. Monte Carlo Simulations
Simulations were conducted on our high-performance computing cluster. Data analysis was performed
using the Python programming language (Python Software Foundation. Python Language Reference, version
3.4.3, www.python.org).
Appendix B.1. Beam model definition
As the proton beam is not mono-energetic, beam energy distributions corresponding to the facility’s
nominal beam energies Enom needed to be determined. For this purpose, in-water depth-dose curves were
measured for 24 energies between 100 MeV and 215 MeV using a multi-layer ionization chamber with 6 cm
radius and an effective depth resolution of 1 mm (Giraffe, IBA Dosimetry, Schwarzenbruck, Germany) [30].
An analytical approximation of the Bragg curve [31] was fitted to the measured data, yielding the proton
range R80 and its energy spread σE . Ranges R80 were converted to mean initial proton energies E0 using
tabulated stopping power data [32]. E0 and σE are given in Table B.2 for all studied energies.
The obtained energies E0 exceeded the nominal energies Enom by 1 MeV to 2 MeV, which can be explained
by the fact that the beam line is calibrated to produce certain beam ranges, whereas the nominal energies
serve as labels. The measured energy spread σE ranged between 0.8 MeV and 1.2 MeV. E0 and σE were
used to define the beam for the Monte Carlo simulations.
If not stated differently, energies mentioned throughout this work refer to the nominal energies.
To acquire a realistic model of the source, 2D beam profiles were measured close to the beam exit
window (in a distance of 8 cm) using a the pixelated scintillation detector for seven energies between 100 MeV
and 215 MeV. A fit of a two-dimensional Gaussian function to the data yielded a mean lateral spread of
σ0
yz = (4.7 ± 0.7)mm with a small trend of decreasing σ0yz with increasing energy and a slightly higher
spread in vertical (z-) direction than in horizontal (y-) direction.
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Table B.2: Beam energy E0 and energy spread σE obtained from fit to depth-dose measurements for nominal energies Enom.
All quantities are in MeV.
Enom E0 σE
100 101.8 0.8
105 107.1 0.9
110 112.2 0.9
115 117.2 1.0
120 121.9 1.0
125 126.7 1.1
130 131.9 1.1
135 137.1 1.1
Enom E0 σE
140 141.8 1.2
145 146.8 1.2
150 151.6 1.2
155 156.9 1.2
160 161.9 1.2
165 166.9 1.2
170 171.7 1.3
175 176.6 1.3
Enom E0 σE
180 181.8 1.3
185 186.8 1.3
190 192.0 1.3
195 196.9 1.3
200 201.7 1.3
205 206.9 1.3
210 211.9 1.3
215 216.9 1.2
Varying the simulated initial beam spread σ0
yz between 0 and 8 mm showed no influence on the
simulated beam spread at the phantom entrance larger than 0.1 mm. Thus, the beam shape at the phantom
entrance is mainly determined by scattering in the 202 cm long air gap between the beam exit and the
phantom and by stopping in the collimators, and not by the initial beam profile. For simplicity, the initial
beam profile was therefore modelled as an energy-independent Gaussian with a fixed unilateral spread of
σ0
yz = 4.7 mm.
Different models of the physical processes involved are available within Geant4, with a set of such process
models being called a physics list. A number of different recommendations for physics lists for proton
therapy have been made in previous studies and by the Geant4 and GATE collaborations: QGSP BIC HP EMY
[33], QGSP BIC HP EMZ, QGSP BERT HP EMY and QGSP BERT HP EMZ, [34], HADRONTHERAPY 1 and HADRONTHERAPY 2 [35],
and QBBC EMY and QBBC EMZ [36, 37]. These physics lists differ mainly in the representation of hadronic and
electromagnetic interactions, as well as low-energy neutron interactions and radioactive decay models. A
detailed description of the relevant models and physics list can be found in [38]. Since there is no clear
consensus within these recommendations for a single superior physics list, all mentioned physics lists were
included and tested in this study.
The ionization potential of water was set to 78 eV, which is the default value for Geant4 version 10 and
higher, and is consistent with the revised ICRU report 73 [39]. Note that this value differs from the one used
in tabulated stopping-power data [32] by 3 eV. Parameters defining the resolution of the simulation, i.e.
secondary particle production threshold, maximum step length and dose scorer resolution, were defined by
a convergence study, meaning that they were reduced until no change in the observables was found within a
required precision. Observables were the proton range and energy spread with a required precision of 0.1 mm
and 0.1 MeV, respectively. For increased simulation efficiency, the secondary particle production threshold
18
was determined independently inside and outside of the phantom (the latter being referred to as world).
The RANMAR random number generator was chosen, as it provides 9× 108 disjoint sequences with a length
of 1030 numbers [40]. The magnetic field was implemented using a corrected version [41] of the Geant4 class
HadrontherapyMagneticField3D given in the HADRONTHERAPY application example of Geant4.
Appendix B.2. Beam model verification
As a verification for the thus defined beam model, depth-dose curves were scored in a water phantom (size
xwp × ywp × zwp = 35× 12× 12 cm3). For 24 energies, the range R0 and energy spread σE were obtained
by fitting the analytical Bragg curve [31] to these depth-dose curves (as in Appendix B.1). These were then
compared to those obtained from the experimental data.
Furthermore, two-dimensional beam profiles were measured at the phantom entrance position behind
the collimators using the pixelated scintillation detector. Profiles were scored in the simulation at the same
position. Spatial spreads at the phantom entrance position σph
yz were extracted by fitting a bivariate
Gaussian function to the obtained experimental and simulated planar dose profiles.
The physics model QGSP BERT HP EMZ showed the smallest deviation to the experimental data and was
thus chosen for the simulation, although differences between the studied models in range and energy spread
were smaller than 0.2 mm and 0.05 MeV, respectively. The minimum required production threshold for the
world was found to be 5 mm and the minimum required production threshold for the phantom, step limiter
and scorer resolution were found to be 0.1 mm. This corresponds well with values found in previous studies
[36, 42].
Mean differences between the model and reference measurements of depth-dose curves and lateral beam
profiles in water without magnetic field (see Appendix B.2), were 0.2 mm in range (max. 0.5 mm), 0.23 MeV
in energy spread (max. 0.35 MeV) and 0.1 mm in spatial spread (max. 0.2 mm). The beam model was thus
accepted for the simulations.
Dose was scored in the PMMA phantom at the position of the film detector, on a 20× 15 cm2 plane
with a thickness of 30 µm corresponding to that of the active layer of a Gafchromic EBT3 film dosimeter
(Ashland, Covington, USA).
We note that the parameters defining the spatial and energy distributions were directly implemented as
measured, and not adjusted iteratively to improve the match between simulated and measured data. This
allowed an unbiased comparison of the different physics lists.
For the deflection study (see main manuscript), the convergence study for the simulation resolution
parameters was repeated with the range and the Bragg peak deflection as observables and a required accuracy
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of 0.1 mm. The same parameters were found as for the model building (5 mm for the world production
threshold, and 0.1 mm for the phantom production threshold, step limiter and scorer resolution). The film
dosimeter was not explicitly simulated to avoid boundary artefacts.
The most relevant simulation parameters are summarized in table B.3.
Table B.3: Geant4 simulation parameters.
Geant4 version 10.2.p02
Physics list QGSP BERT HP EMZ
Production threshold in world 5 mm
Production threshold in phantom 0.1 mm
Step limiter 0.1 mm
Scorer resolution 0.1 mm
Water mean excitation energy 78 eV
Random number generator RANMAR
We note that in the depth-dose curves (see figure 3) of the 180 MeV beams, a small peak is observed at
a depth of about 2.5 cm both with and without magnetic field. The peak was not reproduced when the two
collimators were replaced by one collimator of their combined thickness. Furthermore, the proton energy
spectrum at the phantom entrance showed a steep maximum around 180 MeV and a small maximum around
60 MeV. Thus, a probable explanation for the small peak are low energy protons having traversed only one
of the two collimators.
Appendix B.3. Magnetic field model
A model of the magnetic field was generated using finite-element modelling (COMSOL Multiphysics,
COMSOL AB, Stockholm, Sweden). The geometry of the magnet assembly was implemented as given by the
manufacturer (Vacuumschmelze GmbH, Hanau, Germany) and surrounded by the pre-defined material ’Air’.
The remanent field strength of the magnetic poles was set to Br = 1.37 T, as specified for the VACODYM
764 TP material by the manufacturer [26]. The hysteresis curve B(H) for the yoke was inherited from
the COMSOL material library using the predefined material ’Soft Iron (without losses)’. The model was
validated comprehensively using an automated magnetometry setup comprising a robotic positioning device
and a Hall probe (MMTB-6J04-VG, Lake Shore Cryotronics, Westerville, USA) connected to a Gaussmeter
(Model 421, Lake Shore Cryotronics). Predicted and measured magnetic flux densities agreed within 2 %
[21].
In air, the field of the magnet is mainly limited to the gap between its two poles, and has a maximum
magnetic flux density of 0.95 T (see Figure A.7). Its main component Bz is aligned parallel to the z-axis,
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which leads to a deflection of the proton beam in (positive) y-direction.
A look-up-table (LUT) of the magnetic field was exported from the finite-element model with a grid
spacing of 5 mm in a volume of xB × yB × zB = 70× 40× 20 cm3. The LUT covered the three magnetic
field components in the volume of x ∈ [−50 cm, 20 cm] and y ∈ [−20 cm, 20 cm] and z ∈ [−10 cm, 10 cm].
Appendix B.4. Uncertainty estimation
To assess the influence of the different uncertainties of the simulations, a number of separate Monte Carlo
simulations were performed while varying the input parameters. For each of these uncertainty simulations,
the Bragg peak deflection y80 and retraction ∆R80 were extracted and compared to the original simulations.
All uncertainties were calculated for the lowest (80 MeV) and highest (180 MeV) energy used and interpolated
linearly for intermediate energies.
Relevant systematic uncertainties of the input parameters are those of the initial proton energy E0, of
the density of the PMMA phantom ρ and of the main magnetic field component Bz.
The uncertainty of the range measurements performed for Appendix B.1 amounts to 0.25 mm. Us-
ing tabulated stopping-power data [32], this corresponds to an uncertainty of the beam energy E0 of
∆E0(80 MeV) = 0.25 MeV to ∆E0(180 MeV) = 0.15 MeV. The absolute uncertainty of the PMMA density
amounts to ∆ρ = 0.002 g cm−3, and that of the simulated magnetic field map to ∆Bz = 0.02 T.
Each of these parameters was separately increased by its uncertainty (i.e. E0+∆E, ρ+∆ρ and Bz+∆Bz)
in an additional simulation to assess its influence on y80 and ∆R80. It was assumed that the influence of
the parameter uncertainties was equally large in positive and negative direction.
Furthermore, there is an influence of systematic uncertainties which are inherent to the Monte Carlo
simulation, for example in the physical process models and the mean excitation energy applied. As an
estimate for this uncertainty, the range differences of the model to the reference measurements (Appendix
B.2) of ∆R = 0.2 mm was used. The influence of this range uncertainty on y80 and ∆R80, was assessed by
varying the initial energy accordingly, i.e. with ∆ER0 (80 MeV) = 0.20 MeV to ∆E
R
0 (180 MeV) = 0.12 MeV.
The statistical uncertainty of the simulation was estimated by repeating the original simulation five times
with different random number seeds and calculating the standard deviation of y80 and ∆R80. It was found
that all simulations would be performed with 2.048× 107 primary particles each to acquire a statistical
uncertainty of the Bragg peak position of 0.1 mm or smaller.
The total uncertainty was estimated as the square root of the quadratic sum of the individual contribu-
tions.
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Table B.4: Uncertainties of the predicted lateral deflection ∆y80 and range retraction ∆R80 of the Bragg peak. Lower and
upper limits are given for energy-dependent effects, where lower energies are related to smaller uncertainties.
Source of uncertainty ∆R80/mm y80/mm
Systematic 0.1 ... 0.2 0.1 ... 0.3
Thereof:
Beam energy 0.1 0.0 ... 0.1
Phantom density 0.0 0.1
Magnetic field 0.0 ... 0.1 0.0 ... 0.2
Physics modelling 0.0 ... 0.1 0.0 ... 0.1
Statistical 0.0 ... 0.1 0.0 ... 0.1
Total 0.1 ... 0.2 0.1 ... 0.3
Almost none of the individual uncertainty contributions exceeded the resolution of the dose scoring
grid (0.1 mm). The only exception to this is the uncertainty caused by the magnetic field map, with an
uncertainty of 0.2 mm for the Bragg peak deflection at 180 MeV. With a relative uncertainty of 2 %, the
magnetic field map is the largest factor of uncertainty to this study. The fact that it causes an uncertainty
of approximately 2 % in the Bragg peak deflection is consistent with the proportionality of the two as found
in a previous study [13].
Absolute uncertainties tend to increase with increasing energy, whereas relative uncertainties tend to
decrease. Note that, as the systematic uncertainties were gained in analogous simulations as the main
simulations, they are themselves subject to a statistical uncertainty of up to 0.1 mm.
Appendix C. Depth dose and trajectory reconstruction
Two-dimensional dose distributions D(x, y) were obtained from the film plane. From these, the lateral
(y-) deflection and longitudinal (x-) retraction of the Bragg peak due to the magnetic field were extracted
as follows. For each depth x, a univariate Gaussian function was fitted to the lateral beam profile and
the maximum position yT was extracted. This yielded a function for the lateral maximum dependent on
depth, the beam trajectory yT(x). To mimic a depth-dose curve measured by an ionization chamber of 8 cm
diameter, for each depth the predicted dose was integrated radially around yT with an integration radius
of r = 4 cm. This resulted in a function for the integrated lateral dose dependent on depth, the integral
depth-dose curve
IDD(x) =
∫ 2pi
0
∫ r
0
D(r′, φ)r′dr′dφ = pi
∫ r
−r
D(x, y)|y − yT(x)|dy
with r′ and φ the polar coordinates. Both yT(x) and IDD(x) were smoothed to reduce statistical noise using
a univariate spline fit. The range R80 was calculated from IDD(x) as the depth of the beam at the 80 %
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distal end of the IDD maximum. The longitudinal Bragg peak retraction ∆R80 was defined as the difference
between R80 with and without magnetic field. The lateral Bragg peak deflection y80 was determined from
the trajectory obtained with magnetic field as yT(R80).
Appendix D. Bragg peak displacement
Measured and simulated Bragg peak deflection and retraction values and their uncertainties are summa-
rized in Supporting Table D.5.
Table D.5: Bragg peak displacement caused by the magnetic field in lateral (∆y80) and longitudinal (∆R80) direction for
different proton energies. Positive retraction values indicate that the range with magnetic field is reduced compared to the
reference range without field.
Measurement (EBT3) Simulation (Geant4)
Enom / MeV ∆y80 / mm ∆R80 / mm ∆y80 / mm ∆R80 / mm
80 1.0± 0.4 0.0± 0.5 1.0± 0.1 0.1± 0.1
100 1.7± 0.4 −0.5± 0.5 1.7± 0.1 0.0± 0.1
120 3.2± 0.4 0.3± 0.5 2.9± 0.2 0.1± 0.1
140 4.3± 0.4 −0.2± 0.5 4.6± 0.2 0.2± 0.2
160 6.9± 0.4 −0.2± 0.5 6.7± 0.3 0.2± 0.2
180 10.1± 0.5 0.4± 0.5 9.3± 0.3 0.3± 0.2
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